GW Pharmaceuticals Est. EPS Q/Q
What is the Est. EPS Q/Q of GW Pharmaceuticals?
The Est. EPS Q/Q of GW Pharmaceuticals is 4.17%
What is the definition of Est. EPS Q/Q?
Prospective quarterly EPS growth rate, year over year, is the estimated increase of the company’s EPS for the current quarter compared to performance from a past corresponding quarter.
= current quarter yoy (year over year)
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q/Q of companies in the Health Care sector on NASDAQ compared to GW Pharmaceuticals
Companies with est. eps q/q similar to GW Pharmaceuticals
- Ferro has Est. EPS Q/Q of 4.00%
- Atrium Mortgage Investment has Est. EPS Q/Q of 4.00%
- Kelly Services has Est. EPS Q/Q of 4.00%
- Costco Wholesale Corp has Est. EPS Q/Q of 4.03%
- Akzo Nobel NV has Est. EPS Q/Q of 4.05%
- Amara Raja Batteries has Est. EPS Q/Q of 4.07%
- GW Pharmaceuticals has Est. EPS Q/Q of 4.17%
- Telenet NV has Est. EPS Q/Q of 4.21%
- Chesapeake Utilities Corp has Est. EPS Q/Q of 4.23%
- Bio-Techne Corp has Est. EPS Q/Q of 4.26%
- Ingevity Corp has Est. EPS Q/Q of 4.32%
- Arvind has Est. EPS Q/Q of 4.34%
- Telus has Est. EPS Q/Q of 4.35%